Syncona: Syncona upbeat on interim trial results at Beacon Therapeutics
Syncona announced positive three-month interim results from the phase two 'DAWN' trial conducted by its portfolio company Beacon Therapeutics on Friday.
Read full article »
Syncona is an England-based venture capital firm that invests in early-stage startups.
Read more